科瑞产品

- 客户定制产品 - 前列腺素系列 - PI3K Inhibitors - C-Kit Inhibitors - VEGFR Inhibitors - mTOR Inhibitors - c-Met Inhibitors - DNA/RNA Inhibitors - HER2 Inhibitors - Raf Inhibitors - JAK Inhibitors - Others - SRC Inhibitors - AKT Inhibitors - CDK Inhibitors

浙江省台州市椒江开发大道东段288号万达广场2号楼

0576-88813233

0576-88670057

sales@crene.cn

合作客户/Partner

当前位置：科瑞产品

布瓦西坦 Brivaracetam

规格	价格	库存	数量
在线咨询大包装询价加入购物车

如您需要更多数量的报价，请点击立即获取报价或者通过电子邮件sales@crene.cn把您需要的数量信息提交给我们我们会在第一时间回复您，谢谢！

产品信息

产品名称：布瓦西坦 Brivaracetam	纯度：98% min
CAS NO：357336-20-0	溶解度：Soluble in DMSO
分子式：C₁₁H₂₀N₂O₂	包装：可按客户要求包装
分子量：212.289	贮存：-20℃

质量控制

备注说明

Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties approved for the treatment of epilepsy.

物化属性:

密度：1.062

PSA：63.40000

LOGP：1.53710

参考文献

1: Otoul C, Watanabe S, McCabe S, Stockis A. Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50-mg Film-Coated Tablet. Clin Pharmacol Drug Dev. 2016 Jun 8. doi: 10.1002/cpdd.275. [Epub ahead of print] PubMed PMID: 27274002.

2: Toledo M, Whitesides J, Schiemann J, Johnson ME, Eckhardt K, McDonough B, Borghs S, Kwan P. Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures. Epilepsia. 2016 Jun 6. doi: 10.1111/epi.13416. [Epub ahead of print] PubMed PMID: 27265725.